retatrutide glp 3 GLP-3 RT (LY3437943) Peptide GLP-3 R 30mg - Apollo

No new safety concerns were revealed, which may lead to the introduction of oral forms of Ozempic and Wegovy

Who Should Avoid It: Individuals with a personal or family history of medullary thyroid carcinoma, Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or active pancreatitis

There is no commercially available version

Your healthcare provider will guide you on proper injection techniques and schedules. GLP-1 therapy may not be suitable for individuals with certain medical conditions, such as a history of pancreatitis or medullary thyroid cancer

People with less body fat are more at risk

Those numbers sound bigger than they are: even after the increase, only about 7 in 1,000 GLP-1 patients per year ended up with a hair loss diagnosis, versus roughly 4 to 5 in 1,000 on the other drugs